--- title: "CytoMed Therapeutics (NASDAQ: GDTC) denies false claims, reaffirms progress in cancer treatment research in Singapore." type: "News" locale: "en" url: "https://longbridge.com/en/news/274009965.md" description: "Singapore-based CytoMed Therapeutics Limited (NASDAQ: GDTC) is a clinical stage biopharmaceutical company that specializes in developing affordable donor-derived cell-based immunotherapies for various cancers. The company released a statement in response to recent false claims about its research programs, clinical advancements, and overall operations. This initiative aims to clarify misinformation circulating about CytoMed's work in advancing treatments for a wide spectrum of cancers, encompassing both blood-related and solid tumors." datetime: "2026-01-28T15:02:27.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/274009965.md) - [en](https://longbridge.com/en/news/274009965.md) - [zh-HK](https://longbridge.com/zh-HK/news/274009965.md) --- # CytoMed Therapeutics (NASDAQ: GDTC) denies false claims, reaffirms progress in cancer treatment research in Singapore. Singapore-based CytoMed Therapeutics Limited (NASDAQ: GDTC) is a clinical stage biopharmaceutical company that specializes in developing affordable donor-derived cell-based immunotherapies for various cancers. The company released a statement in response to recent false claims about its research programs, clinical advancements, and overall operations. This initiative aims to clarify misinformation circulating about CytoMed's work in advancing treatments for a wide spectrum of cancers, encompassing both blood-related and solid tumors. ### Related Stocks - [GDTC.US](https://longbridge.com/en/quote/GDTC.US.md) ## Related News & Research - [CytoMed Chairman Moves to Boost Personal Stake Through Private Share Purchases](https://longbridge.com/en/news/286569308.md) - [CareDx to Participate in Upcoming Investor Conferences | CDNA Stock News](https://longbridge.com/en/news/287111110.md) - [Dear Snowflake Stock Fans, Mark Your Calendars for May 27](https://longbridge.com/en/news/287088000.md) - [Microbiotica reports positive results for MB097 in advanced melanoma](https://longbridge.com/en/news/286740265.md) - [Insider Sales And New Institutional Stake Reframe Entegris Valuation Debate](https://longbridge.com/en/news/286662658.md)